WO2004075738A2 - Method and apparatus for continuous electrode impedance monitoring - Google Patents

Method and apparatus for continuous electrode impedance monitoring Download PDF

Info

Publication number
WO2004075738A2
WO2004075738A2 PCT/US2004/006272 US2004006272W WO2004075738A2 WO 2004075738 A2 WO2004075738 A2 WO 2004075738A2 US 2004006272 W US2004006272 W US 2004006272W WO 2004075738 A2 WO2004075738 A2 WO 2004075738A2
Authority
WO
WIPO (PCT)
Prior art keywords
signal
test signal
physiological
component
test
Prior art date
Application number
PCT/US2004/006272
Other languages
French (fr)
Other versions
WO2004075738A3 (en
Inventor
Warwick Freeman
Philip Grosso
Richard Newman
Original Assignee
Compumedics Usa, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compumedics Usa, Inc. filed Critical Compumedics Usa, Inc.
Priority to AU2004215917A priority Critical patent/AU2004215917B2/en
Publication of WO2004075738A2 publication Critical patent/WO2004075738A2/en
Priority to US11/205,373 priority patent/US8068905B2/en
Publication of WO2004075738A3 publication Critical patent/WO2004075738A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6843Monitoring or controlling sensor contact pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/276Protection against electrode failure

Definitions

  • the present invention relates to a method and apparatus for ensuring the accuracy of an acquired physiological signal. More specifically, the present invention is a method of monitoring electrode impedance while receiving an electromagnetic physiological signal.
  • Physiological monitors will often have a testing procedure to check whether the interface between a sensor and the patient being monitored is adequate to acquire a physiological reading. This is especially true with regards to the acquisition of an electrophysiological signal.
  • an electrophysiological signal is acquired through an electrode which is attached to the patient.
  • the contact between an electrode and a patient's skin can significantly affect the results of an electrophysiological signal.
  • High contact impedance generally causes poor quality recordings due to power interference.
  • Electrophysiological signals such as EEG, ECG, EOG and EMG are often distorted by the test current utilized during the test. Consequently, the prior art devices have been unable to continuously monitor the contact impedance between the electrode and the patient.
  • the present invention is a method and apparatus for continuously monitoring a test signal while simultaneously acquiring a physiological signal.
  • the impedance test methods currently employed in electrophysiological recording equipment cause interference to the signal being recorded because the test signal has a frequency (or frequencies in the case of non-sinusoidal test waveforms) within the frequency band of the electrophysiological signal.
  • a digital signal processor DSP
  • a digital band pass filter of the DSP can be used to extract the impedance test signal and electrode impedance from the received signal.
  • the present invention includes a test signal generator capable of producing an impedance test signal comprising of a sine wave having a known frequency.
  • the test signal generator includes a crystal oscillator, a counter, and a lookup table.
  • the lookup table output is applied to a digital to analog converter and is then low pass filtered using a conventional analog filter to produce a test signal comprised of a sine wave having a known frequency and voltage amplitude.
  • the test signal is passed through the electrode and combines with an electrophysiological signal to form a combined signal.
  • a signal processor is used to isolate the combined signal into the test signal component and the electrophysiological component.
  • the signal processor digitally low pass filters the combined signal and the output of the low pass filter is the electrophysiological signal.
  • the signal processor then digitally bandpass filters the combined signal using a filter with a center frequency which is the same as the test frequency. The output of this filter is then used to calculate the electrode impedance.
  • the present invention can be adapted to be integrated into an electrophysiological monitoring system such as EEG, EOG, EMG, and ECG.
  • EEG electrophysiological monitoring system
  • EOG EOG
  • EMG EMG
  • ECG electrophysiological monitoring system
  • a display can be used to monitor both the physiological signal and the contact impedance.
  • FIG. 1 is a block diagram of one embodiment of the present invention.
  • FIG. 2 is a graph of the relationship between a test frequency and a frequency of an electrophysiological signal.
  • FIG. 3 is a block diagram of a system employing one embodiment of the present invention.
  • FIG. 4 is an embodiment of a display in one embodiment of the present invention.
  • the present invention is a method and apparatus for change in electrode impedance monitoring via a combined test and physiological signal. While the embodiment disclosed is particularly adapted to monitor contact impedance and EEG, ECG, EOG, or EMG signals, one skilled in the art can readily adapt the present invention to monitor different parameters which involve the testing of a sensor that is acquiring a physiological signal.
  • the present invention includes a test signal generator capable of producing an impedance test signal comprising of a sine wave having a known frequency, fz 3, which is slightly higher than the frequency range of the electrophysiological signal being monitored.
  • a crystal oscillator 12 provides a known, frequency stable signal to clock the input of a counter 14.
  • the counter output sequentially accesses a lookup table 16 which can be implemented using any digital storage device such as an EPROM or RAM, containing a sine waveform in digital format.
  • the lookup table 16 output is then applied to a digital to analog converter (DAC) 18.
  • the output of the DAC is low pass filtered using a conventional analog filter 20 to produce a sine wave of frequency, fz, and voltage amplitude Vz.
  • a resistor, Rdl with a resistance many times higher than the desired electrode impedance range, converts Vz into a test current Iel .
  • This current flows through the electrode, represented in Figure 1 by Zel, to produce a voltage, Vel, at the input of amplifier 22.
  • Vel voltage
  • Vsl electrophysiological signal
  • the combined signal of Vel + Vsl is amplified and then low pass filtered by anti-aliasing filter 24 before being converted into a digital signal by analog to digital converter (ADC) 26.
  • ADC analog to digital converter
  • the resultant digital signal is read by a digital signal processor (DSP) 30 via multiplexor 28.
  • Figure 1 shows the concept of the present invention extended to n electrode channels, using a separate ADC 26 for each channel, but a single ADC with an analog multiplexor would work equally well.
  • the ADC sampling frequency should be greater than twice fz to prevent aliasing.
  • the DSP 30 should have sufficient computational power to execute both filters for all channels at the desired sample rate plus any storage or display functions. It should be noted that the DSP 30 could alter the sampling frequency, fs, signal bandwidth, fo, and impedance test frequency, fz, provided the relationship to each other is maintained as per Figure 2.
  • the combined signal can be isolated into the test signal component and the electrophysiological component by filtering the combined signal at appropriate frequencies.
  • the DSP 30 digitally low pass filters the combined signal using a filter with a -3dB point, fo, which is lower than the impedance test frequency, fz as shown in Figure 2.
  • the physiological signal, Vsl, alone is the output of the low pass filter.
  • the low pass filter should have a sharp roll-off characteristic so that the test signal component at fz is completely removed.
  • the filter should also have a linear phase characteristic so the physiological signal is not distorted.
  • a symmetrical FIR filter finite impulse response
  • the DSP 30 also digitally bandpass filters the combined signal using a filter with a center frequency of fz, the same as the test frequency.
  • the output of this filter is Vel, as the physiological signal and any higher frequency noise has been removed by the bandpass filter.
  • the bandpass filter may be implemented as either an FIR or an IIR (infinite impulse response) if shorter computation time is needed.
  • Vel will be 50microvolts pk-pk per kilohm of electrode impedance.
  • the impedance of each electrode could be displayed numerically on a computer monitor connected to the DSP ( Figures 3 and 4) or used to activate indicators such as light emitting diodes attached to the amplifier circuit enclosure should the impedance exceed a pre-determined threshold.
  • the present invention can be adapted to be integrated into an electrophysiological monitoring system 30 such as EEG, EOG, EMG, and ECG.
  • EEG electrophysiological monitoring system
  • EOG electronic glycol
  • EMG electrophysiological monitoring system
  • ECG electrophysiological monitoring system
  • a display 32 can be used to monitor both the physiological signal and the contact impedance.
  • the electrophysiological monitor system 30 may also communicate with a central monitoring station 34.
  • the electrophysiological monitor system 30 is adapted to trigger an alarm condition at the central monitoring station 34 should the impedance of any of the electrodes exceed a pre-determined threshold for a pre-determined time (to avoid spurious values triggering the alarm).
  • the operator could set the alarm threshold and the minimum time the threshold needs to be exceeded before the alarm is triggered via a computer network connection to the electrophysiological monitor system 30. This would allow an operator to monitor the contact impedance of each electrode for each patient at a central location remote from the electrophysiological monitor system 30.

Abstract

In one embodiment, the present invention includes a test signal generator capable of producing an impedance test signal comprising of a sine wave having a known frequency. The test signal generator may include a crystal oscillator (12), a counter (14), and a lookup table (16). The lookup table (16) output is applied to a digital to analog converter (18) and is then low pass filtered using a conventional analog filter (20) to produce a sine wave of a known frequency and voltage amplitude. The test signal flows through the electrode and combines with an electrophysiological signal to form a combined signal. A signal processor (30) is used to isolate the combined signal into the test signal component and the electrophysiological component. The signal processor (30) digitally low pass filters the combined signal and the output of the low pass filter is the electrophysiological signal. The signal processor (30) then digitally bandpass filters the combined signal using a filter with a center frequency which is the same as the test frequency. The output of this filter is then used to calculate the electrode impedance.

Description

METHOD AND APPARATUS FOR CONTINUOUS ELECTRODE IMPEDANCE MONITORING
FIELD OF THE INVENTION
Generally, the present invention relates to a method and apparatus for ensuring the accuracy of an acquired physiological signal. More specifically, the present invention is a method of monitoring electrode impedance while receiving an electromagnetic physiological signal.
BACKGROUND OF THE INVENTION
Physiological monitors will often have a testing procedure to check whether the interface between a sensor and the patient being monitored is adequate to acquire a physiological reading. This is especially true with regards to the acquisition of an electrophysiological signal. Typically, an electrophysiological signal is acquired through an electrode which is attached to the patient. The contact between an electrode and a patient's skin can significantly affect the results of an electrophysiological signal. High contact impedance generally causes poor quality recordings due to power interference.
It is a common practice to measure the electrode to skin contact impedance before the start of an electrophysiological recording session. This is done by injecting a small alternating current, Ie, into the electrode and measuring the voltage, Ve, produced across the electrode. The electrode impedance, Ze, may be calculated from the equation Ze = Ve / Ie.
However, most physiological monitors cannot monitor physiological signals during an impedance test because the contact impedance test interferes with the acquisition of the electrophysiological signal. Electrophysiological signals such as EEG, ECG, EOG and EMG are often distorted by the test current utilized during the test. Consequently, the prior art devices have been unable to continuously monitor the contact impedance between the electrode and the patient.
It is not uncommon for electrodes to partially or fully detach from a patient during monitoring, and such an occurrence can seriously distort the electrophysiological signal acquired from the patient. Furthermore, it is often too difficult to visually monitor each electrode on a patient. Consequently, there is a need for an apparatus and a method to continuously monitor the contact impedance between an electrode and a patient without preventing the acquisition of an electrophysiological signal. SUMMARY OF THE INVENTION
The present invention is a method and apparatus for continuously monitoring a test signal while simultaneously acquiring a physiological signal. The impedance test methods currently employed in electrophysiological recording equipment cause interference to the signal being recorded because the test signal has a frequency (or frequencies in the case of non-sinusoidal test waveforms) within the frequency band of the electrophysiological signal. By shifting the test signal to a slightly higher frequency than the electrophysiological signal a digital signal processor (DSP) can be used to low pass filter a received signal to recover and discern the electrophysiological signal from the test signal. A digital band pass filter of the DSP can be used to extract the impedance test signal and electrode impedance from the received signal.
In one embodiment, the present invention includes a test signal generator capable of producing an impedance test signal comprising of a sine wave having a known frequency. The test signal generator includes a crystal oscillator, a counter, and a lookup table. The lookup table output is applied to a digital to analog converter and is then low pass filtered using a conventional analog filter to produce a test signal comprised of a sine wave having a known frequency and voltage amplitude. The test signal is passed through the electrode and combines with an electrophysiological signal to form a combined signal.
In one embodiment, a signal processor is used to isolate the combined signal into the test signal component and the electrophysiological component. The signal processor digitally low pass filters the combined signal and the output of the low pass filter is the electrophysiological signal. The signal processor then digitally bandpass filters the combined signal using a filter with a center frequency which is the same as the test frequency. The output of this filter is then used to calculate the electrode impedance.
In one embodiment, the present invention can be adapted to be integrated into an electrophysiological monitoring system such as EEG, EOG, EMG, and ECG. The contact impedance between an electrode and a patient can be continuously monitored while simultaneously acquiring an electrophysiological signal. A display can be used to monitor both the physiological signal and the contact impedance. BRIEF DESCRIPTION OF THE DRAWINGS
In this disclosure, only certain embodiments are depicted, and not all or every insubstantial change or modification of each such embodiment are depicted or described herein, although those of ordinary skill in the art to which the invention is directed will appreciate many insubstantial changes to the teacliing of this disclosure that nevertheless fall within the spirit and scope of the invention. In this disclosure, reference numerals are used to refer to various elements, sub-elements and process steps and the same reference numeral is intended to denote all similar or identical elements set forth herein.
FIG. 1 is a block diagram of one embodiment of the present invention.
FIG. 2 is a graph of the relationship between a test frequency and a frequency of an electrophysiological signal.
FIG. 3 is a block diagram of a system employing one embodiment of the present invention.
FIG. 4 is an embodiment of a display in one embodiment of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is a method and apparatus for change in electrode impedance monitoring via a combined test and physiological signal. While the embodiment disclosed is particularly adapted to monitor contact impedance and EEG, ECG, EOG, or EMG signals, one skilled in the art can readily adapt the present invention to monitor different parameters which involve the testing of a sensor that is acquiring a physiological signal.
As shown in Figure 1, in one embodiment, the present invention includes a test signal generator capable of producing an impedance test signal comprising of a sine wave having a known frequency, fz 3, which is slightly higher than the frequency range of the electrophysiological signal being monitored. A crystal oscillator 12 provides a known, frequency stable signal to clock the input of a counter 14. The counter output sequentially accesses a lookup table 16 which can be implemented using any digital storage device such as an EPROM or RAM, containing a sine waveform in digital format. The lookup table 16 output is then applied to a digital to analog converter (DAC) 18. The output of the DAC is low pass filtered using a conventional analog filter 20 to produce a sine wave of frequency, fz, and voltage amplitude Vz.
A resistor, Rdl, with a resistance many times higher than the desired electrode impedance range, converts Vz into a test current Iel . This current flows through the electrode, represented in Figure 1 by Zel, to produce a voltage, Vel, at the input of amplifier 22. There will also be an electrophysiological signal, Vsl, at the input of amplifier 22. The combined signal of Vel + Vsl is amplified and then low pass filtered by anti-aliasing filter 24 before being converted into a digital signal by analog to digital converter (ADC) 26. The resultant digital signal is read by a digital signal processor (DSP) 30 via multiplexor 28. Figure 1 shows the concept of the present invention extended to n electrode channels, using a separate ADC 26 for each channel, but a single ADC with an analog multiplexor would work equally well.
The ADC sampling frequency should be greater than twice fz to prevent aliasing. The DSP 30 should have sufficient computational power to execute both filters for all channels at the desired sample rate plus any storage or display functions. It should be noted that the DSP 30 could alter the sampling frequency, fs, signal bandwidth, fo, and impedance test frequency, fz, provided the relationship to each other is maintained as per Figure 2.
In one embodiment, the combined signal can be isolated into the test signal component and the electrophysiological component by filtering the combined signal at appropriate frequencies. The DSP 30 digitally low pass filters the combined signal using a filter with a -3dB point, fo, which is lower than the impedance test frequency, fz as shown in Figure 2. The physiological signal, Vsl, alone is the output of the low pass filter. The low pass filter should have a sharp roll-off characteristic so that the test signal component at fz is completely removed. The filter should also have a linear phase characteristic so the physiological signal is not distorted. A symmetrical FIR filter (finite impulse response) can be readily designed to meet both these requirements.
The DSP 30 also digitally bandpass filters the combined signal using a filter with a center frequency of fz, the same as the test frequency. The output of this filter is Vel, as the physiological signal and any higher frequency noise has been removed by the bandpass filter. The bandpass filter may be implemented as either an FIR or an IIR (infinite impulse response) if shorter computation time is needed. The electrode impedance, Ze, can then be calculated as Ze = Vel / Iel, where Iel = Vz / Rdl, which is a constant. In one example Vz would be 1 volt pk-pk and Rdl = 20 megohms, giving Iel = 50 nanoampers pk-pk. Thus Vel will be 50microvolts pk-pk per kilohm of electrode impedance. The impedance of each electrode could be displayed numerically on a computer monitor connected to the DSP (Figures 3 and 4) or used to activate indicators such as light emitting diodes attached to the amplifier circuit enclosure should the impedance exceed a pre-determined threshold.
As shown in Figs. 3 and 4, in one embodiment, the present invention can be adapted to be integrated into an electrophysiological monitoring system 30 such as EEG, EOG, EMG, and ECG. The contact impedance between an electrode and a patient can be continuously monitored while simultaneously acquiring an electrophysiological signal. A display 32 can be used to monitor both the physiological signal and the contact impedance.
In one embodiment, the electrophysiological monitor system 30 may also communicate with a central monitoring station 34. The electrophysiological monitor system 30 is adapted to trigger an alarm condition at the central monitoring station 34 should the impedance of any of the electrodes exceed a pre-determined threshold for a pre-determined time (to avoid spurious values triggering the alarm). The operator could set the alarm threshold and the minimum time the threshold needs to be exceeded before the alarm is triggered via a computer network connection to the electrophysiological monitor system 30. This would allow an operator to monitor the contact impedance of each electrode for each patient at a central location remote from the electrophysiological monitor system 30.
The matter set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. While a particular embodiment has been shown and described, it will be obvious to those skilled in the art that changes and modifications may be made without departing from the broader aspects of applicant's contribution. The actual scope of the protection sought is intended to be defined in the following claims when viewed in their proper perspective based on the prior art.

Claims

CLAIMSWe claim:
1. A method comprising: sending a test signal to a sensor of physiological data, said sensor having an impedance; receiving a combined signal comprising a physiological signal component and a test signal component; filtering the combined signal to separate the physiological signal component from the test signal component; and detecting changes in the impedance of the sensor by a comparison of test signal components.
2. The method of Claim 1 , wherein the combined signal is filtered using a band pass filter to isolate the test signal component.
3. The method of Claim 2, wherein the test signal is a sine wave having a known frequency.
4. The method of Claim 3, wherein the step of sending a test signal includes using a sine waveform in digital format and applying the sine waveform to a digital to analog converter.
5. The method of Claim 4, wherein the test signal has a higher frequency than the physiological signal component, and wherein filtering includes using a low pass filter on the combined signal to isolate the physiological signal component.
6. The method of Claim 1, and further comprising determining contact impedance between the sensor and a patient's skin from the test signal component.
7. A method comprising communicating a test signal to a sensor of physiological data; combining a physiological signal with the test signal to create a combined signal; and deriving both a physiological waveform and contact impedance from the combined signal.
8. The method of Claim 7, wherein deriving the physiological waveform includes utilizing a low pass filter on the combined signal to isolate a physiological component.
9. The method of Claim 7, wherein deriving the contact impedance includes utilizing a band pass filter on the combined signal to isolate a test signal component.
10. The method of Claim 7, and further comprising simultaneously displaying the physiological waveform and the contact impedance from the combined signal.
11. The method of Claim 7, and further comprising creating an analog test signal having a known frequency by storing a sine wave in digital format and using a digital to analog converter to convert the stored digital sine wave into an analog signal.
12. An apparatus comprising; a test signal generator adapted to deliver a test signal to a sensor; a signal processor adapted to receive a combined signal from the sensor and isolating the combined signal into a physiological component and a test signal component; and a display adapted to display a physiological waveform derived from the physiological component and a contact impedance derived from the test signal component.
13. The apparatus of Claim 12, wherein the test signal generator includes an oscillator, a counter, and a lookup table adapted to create a sine wave in digital format.
14. The apparatus of Claim 13, wherein the test signal generator includes a digital to analog converter in communication with the lookup table.
15. The apparatus of Claim 12, wherein the signal processor includes a band pass filter adapted to isolate the test signal component.
16. The apparatus of Claim 15, wherein the signal processor includes a low pass filter adapted to isolate the physiological component.
17. The apparatus of Claim 12, wherein the sensor is an electrode.
18. The apparatus of Claim 12, wherein the test signal generator, the signal processor and the display are adapted into an EEG machine.
19. The apparatus of Claim 12, wherein the test signal generator, the signal processor and the display are adapted into an ECG machine.
20. The apparatus of Claim 12, wherein the test signal generator, the signal processor and the display are adapted into an EMG machine.
21. The apparatus of Claim 12, wherein the test signal generator, the signal processor and the display are adapted into an EOG machine.
PCT/US2004/006272 2003-02-26 2004-02-26 Method and apparatus for continuous electrode impedance monitoring WO2004075738A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2004215917A AU2004215917B2 (en) 2003-02-26 2004-02-26 Method and apparatus for continuous electrode impedance monitoring
US11/205,373 US8068905B2 (en) 2004-02-26 2005-08-17 Method and apparatus for continuous electrode impedance monitoring

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45113003P 2003-02-26 2003-02-26
US60/451,130 2003-02-26

Publications (2)

Publication Number Publication Date
WO2004075738A2 true WO2004075738A2 (en) 2004-09-10
WO2004075738A3 WO2004075738A3 (en) 2005-11-03

Family

ID=32927701

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/006272 WO2004075738A2 (en) 2003-02-26 2004-02-26 Method and apparatus for continuous electrode impedance monitoring

Country Status (2)

Country Link
AU (1) AU2004215917B2 (en)
WO (1) WO2004075738A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795122A1 (en) * 2005-12-12 2007-06-13 General Electric Company Detection of artifacts in bioelectric signals
FR2908973A1 (en) * 2006-11-24 2008-05-30 Yves Faisandier Electrical physiological signal i.e. ECG signal, recording method for ambulatory apparatus, involves associating impedance measurement of electrodes with amplification and digitization of signal to provide signals charged with information
WO2017222888A1 (en) * 2016-06-22 2017-12-28 General Electric Company System and method for rapid ecg acquisition
CN109419502A (en) * 2017-08-29 2019-03-05 韦伯斯特生物官能(以色列)有限公司 For sensing the medical patch of ECG signal and impedance instruction electric signal simultaneously

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9594104B2 (en) 2014-10-22 2017-03-14 Natus Medical Incorporated Simultaneous impedance testing method and apparatus

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4993423A (en) * 1988-07-13 1991-02-19 Physio-Control Corporation Method and apparatus for differential lead impedance comparison
US5042498A (en) * 1990-04-06 1991-08-27 Hewlett-Packard Company Intelligent electrocardiogram system
US6007532A (en) * 1997-08-29 1999-12-28 3M Innovative Properties Company Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610254A (en) * 1984-03-08 1986-09-09 Physio-Control Corporation Interactive portable defibrillator
US6487449B1 (en) * 2000-05-23 2002-11-26 Ge Medical Systems Information Technologies, Inc. Method and apparatus for reducing noise and detecting electrode faults in medical equipment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4993423A (en) * 1988-07-13 1991-02-19 Physio-Control Corporation Method and apparatus for differential lead impedance comparison
US5042498A (en) * 1990-04-06 1991-08-27 Hewlett-Packard Company Intelligent electrocardiogram system
US6007532A (en) * 1997-08-29 1999-12-28 3M Innovative Properties Company Method and apparatus for detecting loss of contact of biomedical electrodes with patient skin

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795122A1 (en) * 2005-12-12 2007-06-13 General Electric Company Detection of artifacts in bioelectric signals
US7684856B2 (en) 2005-12-12 2010-03-23 General Electric Company Detection of artifacts in bioelectric signals
FR2908973A1 (en) * 2006-11-24 2008-05-30 Yves Faisandier Electrical physiological signal i.e. ECG signal, recording method for ambulatory apparatus, involves associating impedance measurement of electrodes with amplification and digitization of signal to provide signals charged with information
WO2017222888A1 (en) * 2016-06-22 2017-12-28 General Electric Company System and method for rapid ecg acquisition
US10278602B2 (en) 2016-06-22 2019-05-07 General Electric Company System and method for rapid ECG acquisition
US11051740B2 (en) 2016-06-22 2021-07-06 General Electric Company System and method for rapid ECG acquisition
CN109419502A (en) * 2017-08-29 2019-03-05 韦伯斯特生物官能(以色列)有限公司 For sensing the medical patch of ECG signal and impedance instruction electric signal simultaneously

Also Published As

Publication number Publication date
AU2004215917B2 (en) 2008-01-10
AU2004215917A1 (en) 2004-09-10
WO2004075738A3 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
US20060020218A1 (en) Method and apparatus for continuous electrode impedance monitoring
US7894885B2 (en) Coherent signal rejection in ECG
US6493576B1 (en) Method and apparatus for measuring stimulus-evoked potentials of the brain
RU2107460C1 (en) Method and device for recording galvanic skin responses
US8089283B2 (en) Apparatus and method for high-speed determination of bioelectric electrode impedances
JP2004531353A (en) Bioelectrical impedance measurement system and method in the presence of interference
WO2004027981A2 (en) Handheld low voltage testing device
WO2013185775A1 (en) Method and system of detecting seizures
Affanni et al. Wearable instrument for skin potential response analysis in AAL applications
KR100455276B1 (en) Method and apparatus for detecting leadfailure in electrocardigram
AU2004215917B2 (en) Method and apparatus for continuous electrode impedance monitoring
JP4890474B2 (en) Method and apparatus for monitoring a sedated patient
JPS585057B2 (en) EKG interelectrode impedance measuring device
AU2006211808B2 (en) Method and apparatus for monitoring a sedated patient
US6701182B1 (en) Method and apparatus for analyzing a physiological waveform
Margolis et al. Methods for measuring the temporal characteristics and filter response of electroacoustic impedance instruments
US20220387746A1 (en) Method and apparatus for assessing an effect of a relaxation stimulus exposed to a human
KR930002543Y1 (en) Pulse recoder and displayer combind with computer
RU2107487C1 (en) Method and device for performing electroacupuncture diagnosis procedure taking into account mechanical and electric properties of acupuncture points
Pinheiro et al. A practical approach concerning heart rate variability measurement and arrhythmia detection based on virtual instrumentation
Burgar et al. Proposed standard measurement techniques for the technical specification of biofeedback devices
Chaudhuri et al. Calibration of Locket
Link et al. Variability of QRS-shape and heart rate in magneto/electrocardiograms of healthy subjects and risk patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11205373

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004215917

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004215917

Country of ref document: AU

Date of ref document: 20040226

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004215917

Country of ref document: AU

122 Ep: pct application non-entry in european phase
ENP Entry into the national phase

Ref document number: 2004215917

Country of ref document: AU

Date of ref document: 20040226

Kind code of ref document: B